Published in Proc Natl Acad Sci U S A on September 01, 2009
Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10
The gut microbiota--masters of host development and physiology. Nat Rev Microbiol (2013) 5.25
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
The microbiome in infectious disease and inflammation. Annu Rev Immunol (2012) 3.76
Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol (2012) 3.21
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest (2013) 2.96
Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology (2011) 2.90
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Control of pathogens and pathobionts by the gut microbiota. Nat Immunol (2013) 2.84
ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology (2010) 2.83
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity (2011) 2.47
Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe (2011) 2.46
The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol (2011) 2.26
Intestinal commensal microbes as immune modulators. Cell Host Microbe (2012) 2.07
Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. Immunity (2011) 1.96
Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity (2014) 1.94
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A (2010) 1.90
Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma. Cell Host Microbe (2010) 1.85
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis (2010) 1.84
Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One (2012) 1.82
Mouse Paneth cell antimicrobial function is independent of Nod2. Gut (2013) 1.69
A crypt-specific core microbiota resides in the mouse colon. MBio (2012) 1.64
Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol (2010) 1.59
NLR functions beyond pathogen recognition. Nat Immunol (2011) 1.57
The evolution of mutualism in gut microbiota via host epithelial selection. PLoS Biol (2012) 1.55
Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol (2013) 1.53
Exploring host-microbiota interactions in animal models and humans. Genes Dev (2013) 1.51
Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A (2010) 1.50
Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol (2010) 1.50
Investigating the biological and clinical significance of human dysbioses. Trends Microbiol (2011) 1.48
The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol (2013) 1.41
Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep (2012) 1.37
Peyer's Patches: The Immune Sensors of the Intestine. Int J Inflam (2010) 1.32
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One (2012) 1.28
Crohn's disease: NOD2, autophagy and ER stress converge. Gut (2011) 1.27
The potter's wheel: the host's role in sculpting its microbiota. Cell Mol Life Sci (2011) 1.25
NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity (2014) 1.24
Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism. ISME J (2014) 1.23
Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes. J Exp Med (2013) 1.21
Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS One (2012) 1.20
The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol (2010) 1.15
The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis (2011) 1.15
Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol (2010) 1.14
Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu Rev Immunol (2013) 1.13
A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses. J Biol Chem (2010) 1.11
The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol (2014) 1.11
Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes (2013) 1.10
Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol (2012) 1.09
The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol (2011) 1.09
Animal models of IBD: linkage to human disease. Curr Opin Pharmacol (2010) 1.08
Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol (2013) 1.07
The microbiome and innate immunity. Nature (2016) 1.05
Microbiota-immune system interaction: an uneasy alliance. Curr Opin Microbiol (2010) 1.05
The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish. Dis Model Mech (2011) 1.04
Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis (2010) 1.03
Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis (2016) 1.02
The microbial basis of inflammatory bowel diseases. J Clin Invest (2014) 1.01
Influence of dietary components on regulatory T cells. Mol Med (2012) 1.01
Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med (Berl) (2011) 1.01
Innate immunity in the small intestine. Curr Opin Gastroenterol (2011) 1.01
Innate immune signaling in defense against intestinal microbes. Immunol Rev (2012) 1.00
The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol (2013) 1.00
Immune-microbiota interactions in health and disease. Clin Immunol (2015) 0.99
TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi. Infect Immun (2012) 0.99
Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform. PLoS One (2013) 0.99
Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in mice. ISME J (2012) 0.98
Intestinal barrier in inflammatory bowel disease. World J Gastroenterol (2014) 0.97
RIP2 activity in inflammatory disease and implications for novel therapeutics. J Leukoc Biol (2013) 0.97
The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS One (2011) 0.95
Host-microbe interactions shaping the gastrointestinal environment. Trends Immunol (2014) 0.95
Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii. Eur J Immunol (2011) 0.95
Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components. J Biol Chem (2012) 0.94
The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol (2015) 0.93
Genome-Wide Association Studies of the Human Gut Microbiota. PLoS One (2015) 0.93
Intestinal epithelial cells and their role in innate mucosal immunity. Cell Tissue Res (2010) 0.92
NOD-Like Receptors in Lung Diseases. Front Immunol (2013) 0.92
International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease. Pharmacol Rev (2015) 0.92
From lifetime to evolution: timescales of human gut microbiota adaptation. Front Microbiol (2014) 0.91
Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS One (2011) 0.91
Immune and genetic gardening of the intestinal microbiome. FEBS Lett (2014) 0.91
The intermediate filament protein, vimentin, is a regulator of NOD2 activity. Gut (2012) 0.91
Inflammatory bowel disease: an impaired barrier disease. Langenbecks Arch Surg (2012) 0.91
The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway. Cell Mol Immunol (2016) 0.91
Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol (2015) 0.91
Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn's Disease. Am J Gastroenterol (2016) 0.90
Comparative analysis of the intestinal bacterial communities in different species of carp by pyrosequencing. Microb Ecol (2014) 0.90
Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol (2013) 0.90
Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis. PLoS One (2014) 0.88
The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells. Gastroenterology (2012) 0.88
Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc Natl Acad Sci U S A (2013) 0.88
Antimicrobial proteins in intestine and inflammatory bowel diseases. Intest Res (2014) 0.88
A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions. Mucosal Immunol (2014) 0.87
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm (2015) 0.87
Diversity and variability of NOD-like receptors in fungi. Genome Biol Evol (2014) 0.87
Intestinal antimicrobial peptides during homeostasis, infection, and disease. Front Immunol (2012) 0.86
Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria. PLoS One (2013) 0.86
Antimicrobial peptides in gastrointestinal inflammation. Int J Inflam (2010) 0.86
The role of the immune system in regulating the microbiota. Gut Microbes (2010) 0.85
Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. Inflamm Bowel Dis (2011) 0.85
Diversity of the human intestinal microbial flora. Science (2005) 49.64
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem (2003) 9.37
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell (2008) 8.43
The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol (2008) 7.91
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature (2002) 5.95
Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A (2008) 5.78
Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature (2008) 4.87
The NLR gene family: a standard nomenclature. Immunity (2008) 4.77
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature (2008) 4.42
Dendritic cells in intestinal immune regulation. Nat Rev Immunol (2008) 4.20
MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med (2007) 3.79
Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem (2002) 3.27
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut (2008) 2.90
Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut (2003) 2.74
Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology (2003) 2.72
Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Appl Environ Microbiol (2006) 2.58
Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet (2004) 2.23
Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol (2003) 2.12
Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol (2005) 1.93
NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol (2007) 1.73
Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis (2007) 1.73
Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter (1998) 1.61
Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment. Mamm Genome (2006) 1.44
Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol (2007) 1.40
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun (2000) 1.33
Genotypes and phenotypes in Crohn's disease: do they help in clinical management? Gut (2005) 1.23
Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut (2009) 1.11
Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol (2008) 1.07
Discrimination of Bacillus cereus and Bacillus thuringiensis with 16S rRNA and gyrB gene based PCR primers and sequencing of their annealing sites. J Appl Microbiol (2002) 1.03
MDP and other muropeptides--direct and synergistic effects on the immune system. J Endotoxin Res (2006) 1.01
Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J Cell Physiol (2006) 1.01
Carbamylcholine- and catecholamine-induced intracellular calcium dynamics of epithelial cells in mouse ileal crypts. Gastroenterology (1995) 0.93
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity (2006) 5.40
The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol (2006) 4.70
Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol (2006) 3.70
Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. J Cell Biol (2003) 2.12
Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem (2007) 2.06
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A (2010) 1.90
A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation. Immunity (2008) 1.78
NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J Leukoc Biol (2007) 1.73
NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol (2008) 1.73
Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis (2007) 1.73
Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog (2008) 1.70
MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3. J Leukoc Biol (2007) 1.67
Patterns of early gut colonization shape future immune responses of the host. PLoS One (2012) 1.56
Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A (2010) 1.50
Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol (2008) 1.35
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy. J Am Soc Nephrol (2013) 1.31
NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression. J Immunol (2012) 1.29
Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe (2012) 1.28
Direct observation of percolation in a manganite thin film. Science (2002) 1.26
Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J Immunol (2009) 1.16
IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation. J Exp Med (2005) 1.15
Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One (2011) 1.15
Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol (2010) 1.14
Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila. Infect Immun (2010) 1.13
The pattern recognition receptors Nod1 and Nod2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect (2010) 1.10
NLRC5: a newly discovered MHC class I transactivator (CITA). Microbes Infect (2011) 1.09
Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb (2010) 1.09
The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochem Biophys Res Commun (2012) 1.07
A role for IL-1 receptor-associated kinase-M in prostaglandin E2-induced immunosuppression post-bone marrow transplantation. J Immunol (2010) 1.07
Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator. J Immunol (2012) 1.05
Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells. Gastroenterology (2012) 1.04
Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J Mol Med (Berl) (2011) 1.01
Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int J Oncol (2008) 1.00
Cytokine profiling in human colostrum and milk by protein array. Clin Chem (2007) 0.99
TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A (2011) 0.98
Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology (2006) 0.98
Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm Bowel Dis (2013) 0.97
The role of RIP2 in p38 MAPK activation in the stressed heart. J Biol Chem (2008) 0.96
Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii. Eur J Immunol (2011) 0.95
Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol (2003) 0.95
Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components. J Biol Chem (2012) 0.94
MyD88-dependent signaling contributes to host defense against ehrlichial infection. PLoS One (2010) 0.93
Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A. Infect Immun (2011) 0.92
Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1. Vaccine (2013) 0.92
Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS One (2011) 0.91
Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia. Mol Med (2012) 0.91
Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs. APMIS (2012) 0.90
Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus. Ann Rheum Dis (2011) 0.89
Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc Natl Acad Sci U S A (2009) 0.89
Intracellular invasion of Orientia tsutsugamushi activates inflammasome in asc-dependent manner. PLoS One (2012) 0.88
Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia. J Infect Dis (2012) 0.86
Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm Bowel Dis (2011) 0.85
Caco-2 cell monolayer integrity and effect of probiotic Escherichia coli Nissle 1917 components. Neuro Endocrinol Lett (2010) 0.85
IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori. PLoS One (2013) 0.84
Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity. J Immunotoxicol (2009) 0.84
A novel aminosaccharide compound blocks immune responses by Toll-like receptors and nucleotide-binding domain, leucine-rich repeat proteins. J Biol Chem (2010) 0.84
IL-1 receptor-associated kinase M downregulates DSS-induced colitis. Inflamm Bowel Dis (2010) 0.83
Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol (2012) 0.83
Effect of bacterial monoassociation on brush-border enzyme activities in ex-germ-free piglets: comparison of commensal and pathogenic Escherichia coli strains. Microbes Infect (2006) 0.83
Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol Lett (2007) 0.83
The effect of weaning on the clonality of alpha beta T-cell receptor T cells in the intestine of GF and SPF mice. Dev Comp Immunol (2006) 0.82
Vibrio cholerae hemolysin is apoptogenic to peritoneal B-1a cells but its oligomer shepherd the cells for IgA response. Mol Immunol (2007) 0.82
Intracellular debugging. Nat Immunol (2003) 0.82
Regulation of intestinal microbiota by the NLR protein family. Int Immunol (2013) 0.81
Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd (2011) 0.81
Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1. Cardiovasc Res (2009) 0.80
Porin-incorporated liposome induces Toll-like receptors 2- and 6-dependent maturation and type 1 response of dendritic cell. Int Immunol (2008) 0.79
Identification of Drosophila Yin and PEPT2 as evolutionarily conserved phagosome-associated muramyl dipeptide transporters. J Biol Chem (2010) 0.79
Influence of probiotics on rat liver biotransformation enzymes. Neuro Endocrinol Lett (2009) 0.78
Absorption kinetics of 5-aminosalicylic acid in rat: influence of indomethacin-induced gastrointestinal lesions and Escherichia Coli Nissle 1917 medication. Neuro Endocrinol Lett (2011) 0.78
Colostrum of healthy mothers contains broad spectrum of secretory IgA autoantibodies. J Clin Immunol (2012) 0.78
Exploring the potential of Nelumbo nucifera rhizome on membrane stabilization, mast cell protection, nitric oxide synthesis, and expression of costimulatory molecules. Immunopharmacol Immunotoxicol (2010) 0.77
Effects of Lactobacillus casei on the expression and the activity of cytochromes P450 and on the CYP mRNA level in the intestine and the liver of male rats. Neuro Endocrinol Lett (2011) 0.77
Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis. BMC Gastroenterol (2011) 0.76
Sperm cells induce distinct cytokine response in peripheral mononuclear cells from infertile women with serum anti-sperm antibodies. PLoS One (2012) 0.75